Myasthenia gravis (MG) is an acquired autoimmune disorder characterized dinically by weakness of skeletal muscles and fatigability on exercise. Weakness increases during the day and improves with rest. Extraocular muscle (EOM) weakness or ptosis is present initially in 50% of patients and 90% accurs during the course of illness. AChE inhibitors and imunomodulating therapies are the mainstays of…
Myasthenia gravis (MG) is an acquired autoimmune disorder characterized dinically by weakness of skeletal muscles and fatigability on exercise. Weakness increases during the day and improves with rest. Extraocular muscle (EOM) weakness or ptosis is present initially in 50% of patients and 90% accurs during the course of illness. AChE inhibitors and imunomodulating therapies are the mainstays of…